Effects of liraglutide on obesity-associated functional hypogonadism in men

Lifestyle measures (LSMs) should be the first-line approach offered for obesity-related functional hypogonadism (FH). When LSMs fail, the role of testosterone replacement treatment (TRT) is unclear. GLP1 receptor agonist liraglutide is linked to progressive and sustained weight loss. A potential dir...

Descripción completa

Detalles Bibliográficos
Autores principales: Jensterle, M, Podbregar, A, Goricar, K, Gregoric, N, Janez, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391904/
https://www.ncbi.nlm.nih.gov/pubmed/30707677
http://dx.doi.org/10.1530/EC-18-0514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391904/
https://www.ncbi.nlm.nih.gov/pubmed/30707677
http://dx.doi.org/10.1530/EC-18-0514

Ejemplares similares